Literature DB >> 26622447

microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.

Cheng Zhao1, Lin Qi1, Minfeng Chen1, Longfei Liu1, Weiqian Yan2, Shiyu Tong1, Xiongbing Zu1.   

Abstract

microRNA (miR)-195 acts as a suppressor in multiple types of malignant tumors, including bladder cancer; however, the detailed function of miR-195 in bladder cancer remains largely unknown. The aim of the present study was to investigate the role of miR-195 in the regulation of bladder cancer cell proliferation and to determine whether cell division control protein 42 homolog (Cdc42)/signal transducer and activator of transcription-3 (STAT3) signaling acts as a downstream effector of miR-195 in bladder cancer cells. Reverse transcription-quantitative polymerase chain reaction was used to determine the expression levels of miR-195 in bladder cancer tissues and normal adjacent tissue. The results revealed that the expression of miR-195 was significantly downregulated in bladder cancer tissues compared with that in the normal adjacent tissues. A luciferase reporter assay was then conducted, which identified Cdc42 as a direct target of miR-195, and the expression of Cdc42 was significantly upregulated in bladder cancer tissues, as determined by western blotting. Furthermore, miR-195 negatively regulated the protein expression of Cdc42 in bladder cancer cells. An MTT assay was also conducted to determine the rate of cell proliferation. Upregulation of miR-195 or the inhibition of Cdc42 could inhibit bladder cancer cell proliferation, possibly through activation of STAT3 signaling. In addition, restoration of Cdc42 could reverse the inhibitory effect of miR-195 upregulation on bladder cancer cell proliferation. In conclusion, the results of the present study suggest that miR-195 plays an inhibitory role in the regulation of bladder cancer cell proliferation by directly targeting Cdc42/STAT3 signaling.

Entities:  

Keywords:  bladder cancer; cell division control protein 42 homolog; microRNA-195; proliferation

Year:  2015        PMID: 26622447      PMCID: PMC4533204          DOI: 10.3892/etm.2015.2633

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.

Authors:  Xiang Fei; Manlong Qi; Bin Wu; Yongsheng Song; Yueping Wang; Tingting Li
Journal:  FEBS Lett       Date:  2012-01-16       Impact factor: 4.124

Review 3.  Bladder cancer biomarkers: review and update.

Authors:  Soudeh Ghafouri-Fard; Leili Nekoohesh; Elahe Motevaseli
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 4.  The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Authors:  Leda Raptis; Rozanne Arulanandam; Mulu Geletu; James Turkson
Journal:  Exp Cell Res       Date:  2011-05-18       Impact factor: 3.905

5.  Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.

Authors:  Lei Ma; Xubin Deng; Minhua Wu; Gong Zhang; Jianqing Huang
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

6.  Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Authors:  Andliena Tahiri; Suvi-Katri Leivonen; Torben Lüders; Israel Steinfeld; Miriam Ragle Aure; Jürgen Geisler; Rami Mäkelä; Silje Nord; Margit L H Riis; Zohar Yakhini; Kristine Kleivi Sahlberg; Anne-Lise Børresen-Dale; Merja Perälä; Ida R K Bukholm; Vessela N Kristensen
Journal:  Carcinogenesis       Date:  2013-10-08       Impact factor: 4.944

7.  Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.

Authors:  O Chabre; R Libé; G Assie; O Barreau; J Bertherat; X Bertagna; J-J Feige; N Cherradi
Journal:  Endocr Relat Cancer       Date:  2013-07-05       Impact factor: 5.678

8.  A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.

Authors:  Karin Zins; Trevor Lucas; Patrick Reichl; Dietmar Abraham; Seyedhossein Aharinejad
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 9.  Extracellular microRNAs in urologic malignancies: chances and challenges.

Authors:  Xiaoyi Huang; Meihua Liang; Rachel Dittmar; Liang Wang
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

10.  The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.

Authors:  Toshihiko Itesako; Naohiko Seki; Hirofumi Yoshino; Takeshi Chiyomaru; Takeshi Yamasaki; Hideo Hidaka; Tomokazu Yonezawa; Nijiro Nohata; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more
  10 in total

1.  CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras/ERK Pathway.

Authors:  Gang Li; Yu Wang; Xiao-Bo Guo; Bo Zhao
Journal:  Biochem Genet       Date:  2022-04-12       Impact factor: 1.890

Review 2.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

3.  Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195.

Authors:  Hui Zhang; Dong Zhou; Mingang Ying; Minyong Chen; Peng Chen; Zhaoshuo Chen; Fan Zhang
Journal:  Med Sci Monit       Date:  2016-12-09

4.  MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.

Authors:  Yu Shuang; Chao Li; Xuan Zhou; Yongwang Huang; Lun Zhang
Journal:  Oncol Rep       Date:  2017-08-03       Impact factor: 3.906

Review 5.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

Review 6.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

Review 7.  MicroRNA-195: a review of its role in cancers.

Authors:  Wanpeng Yu; Xiao Liang; Xiangdong Li; Yuan Zhang; Zhenqing Sun; Ying Liu; Jianxun Wang
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

8.  Identification of bladder cancer prognostic biomarkers using an ageing gene-related competitive endogenous RNA network.

Authors:  Changliang Wang; Liang Chen; Yang Yang; Menglei Zhang; Garry Wong
Journal:  Oncotarget       Date:  2017-12-04

9.  Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells.

Authors:  Xue-Qian Qian; Sang-Sang Tang; Yuan-Ming Shen; Li-Li Chen; Xiao-Dong Cheng; Xiao-Yun Wan
Journal:  Int J Med Sci       Date:  2020-05-18       Impact factor: 3.738

Review 10.  Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data.

Authors:  Matteo Giulietti; Giulia Occhipinti; Alessandra Righetti; Massimo Bracci; Alessandro Conti; Annamaria Ruzzo; Elisabetta Cerigioni; Tiziana Cacciamani; Giovanni Principato; Francesco Piva
Journal:  Front Oncol       Date:  2018-10-12       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.